Morgan Stanley
  • Research
  • Dec 16, 2021

Moderna CEO Stéphane Bancel: Omicron and the Future of mRNA Tech

As the world potentially faces future COVID-19 variants, are we stuck with the virus forever? Morgan Stanley Biotech Equity Analyst Matthew Harrison sits down with Stéphane Bancel, CEO of Moderna.


How do today’s most influential C-suite executives navigate a period of historic disruption, marked by a pandemic, tech innovation, rapidly evolving business models, trade tensions and the effects of geopolitics on global business?

On Morgan Stanley's new series, Exceptional Leaders/Exceptional Ideas, the firm's equity analysts sit down with leaders at world-class global companies to answer these questions, unpacking broad foundational changes in sectors, industries and markets.

For more Ideas, visit

Watch More Exceptional Leaders Episodes